[ad_1] Looking forward to presenting at the WET AMD AND DME DRUG DEVELOPMENT SUMMIT https://t.co/DxRVXdwQia in Boston April 5-7. Senior leaders of discovery, translational sciences, and #clinicaldevelopment will review programs for wet #AMD, #diabeticretinopathy and #macularedema. https://t.co/s14PPW7r2q [ad_2] Source by Thomas Ciulla, MD, MBA Return …
[ad_1] RT @eurotimes: Ongoing clinical studies exploring subretinal and suprachoroidal administration are showing promising results in the treatme… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @eyetubenet: Want to Know More About the Future of Suprachoroidal Injections? Check out this CME series featuring a New Supplement & on-…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Honored to be recognized as a Castle Connolly Top Doctor, by peer vote, for 2022, and for the past 10 years. https://t.co/6qltcliX6U #eye #ophthalmology #retina #ASRS #clinicalresearch #clinicaltrials #medicine https://t.co/g3aRVlBj0k [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Dr Steven Yeh Discusses Xipere Delivery Mechanism and Benefits https://t.co/F1QDT92Tcm via @AJMC_Journal [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @fightblindness: Announced today, our own Dr. Ben Yerxa has been appointed to the Board of Directors at @clearsidebio, a #biopharmaceuti…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @RD_Fund: Ben Yerxa has been appointed to the Board of Directors of @clearsidebio, a biopharmaceutical company revolutionizing the deliv… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @RetinaToday: Despite its excellent safety profile, intravitreal delivery of certain meds poses inherent limitations. This has been addr… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just published in AJO: https://t.co/3CP1ggDwGG “Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema”. This longitudinal modeling figure shows how anatomic precedes visual improvement after treatment for uveitic macular edema.
#eye #retina https://t.co/Iw5VUjcikj
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @eyewireplus: .@REGENXBIO announced additional positive interim data from the ongoing phase 2 ALTITUDE trial of RGX-314 for the treatmen… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.